Literature DB >> 12112453

Influence of stimulants on electrodermal studies in Fragile X syndrome.

Randi J Hagerman1, Lucy J Miller, Jude McGrath-Clarke, Karen Riley, Edward Goldson, Susan W Harris, Jody Simon, Kelly Church, Julie Bonnell, Todd C Ognibene, Daniel N McIntosh.   

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is seen in the majority of children with Fragile X Syndrome (FraX). Previous work has documented an enhanced sweat response to stimuli in children with FraX compared to controls utilizing electrodermal response (EDR) measures. The present study assesses the EDRs both on and off stimulants in 19 children with ADHD and FraX compared to 17 age- and IQ-matched control patients with ADHD and developmental delays. Although the baseline EDRs were comparable between FraX patients and controls, the patients with FraX had a significant decrease in EDR amplitude and number of peaks when treated with stimulants compared to controls. This suggests that patients with FraX are more responsive to the enhancement of inhibitory systems that occur with stimulant use for ADHD. The use of a quantifiable measure, such as EDR, is recommended in future studies of treatment efficacy. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112453     DOI: 10.1002/jemt.10067

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  13 in total

Review 1.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  Diagnostic validity of sensory over-responsivity: a review of the literature and case reports.

Authors:  Stacey Reynolds; Shelly J Lane
Journal:  J Autism Dev Disord       Date:  2007-10-05

3.  Cardiovascular and behavioral response to auditory stimuli in boys with fragile X syndrome.

Authors:  Jane E Roberts; Anna C J Long; Lindsay M McCary; Amy N Quady; Bonnie S Rose; Dean Widrick; Grace Baranek
Journal:  J Pediatr Psychol       Date:  2012-11-11

4.  Autonomic regulation in fragile X syndrome.

Authors:  Keri J Heilman; Emily R Harden; Danielle M Zageris; Elizabeth Berry-Kravis; Stephen W Porges
Journal:  Dev Psychobiol       Date:  2011-05-05       Impact factor: 3.038

5.  TMS: using the theta-burst protocol to explore mechanism of plasticity in individuals with Fragile X syndrome and autism.

Authors:  Lindsay M Oberman; Jared C Horvath; Alvaro Pascual-Leone
Journal:  J Vis Exp       Date:  2010-12-28       Impact factor: 1.355

6.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

Review 7.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Taurine regulation of short term synaptic plasticity in fragile X mice.

Authors:  Abdeslem El Idrissi; Lorenz S Neuwirth; William L'Amoreaux
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 9.  Advances in the treatment of fragile X syndrome.

Authors:  Randi J Hagerman; Elizabeth Berry-Kravis; Walter E Kaufmann; Michele Y Ono; Nicole Tartaglia; Ave Lachiewicz; Rebecca Kronk; Carol Delahunty; David Hessl; Jeannie Visootsak; Jonathan Picker; Louise Gane; Michael Tranfaglia
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  Physiological and behavioral differences in sensory processing: a comparison of children with autism spectrum disorder and sensory modulation disorder.

Authors:  Sarah A Schoen; Lucy J Miller; Barbara A Brett-Green; Darci M Nielsen
Journal:  Front Integr Neurosci       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.